• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Severe COVID-19 and inactivated vaccine in diabetic patients with SARS-CoV-2 infection.

作者信息

Yang Yaling, Wei Feng, Qu Duoduo, Xu Xinyue, Wu Chenwei, Zhou Lihua, Liu Jia, Zhu Qin, Wang Chunhong, Yan Weili, Zhao Xiaolong

机构信息

Department of Endocrinology, Shanghai Public Health Clinical Center, Shanghai 200080, China.

Department of Chronic Disease Prevention, Shanghai Pudong New Area Center for Disease Prevention and Control, Shanghai 200129, China.

出版信息

Chin Med J (Engl). 2025 May 20;138(10):1257-1259. doi: 10.1097/CM9.0000000000003577. Epub 2025 Apr 23.

DOI:10.1097/CM9.0000000000003577
PMID:40264377
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12091635/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2be6/12091635/512889fbf674/cm9-138-1257-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2be6/12091635/512889fbf674/cm9-138-1257-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2be6/12091635/512889fbf674/cm9-138-1257-g001.jpg

相似文献

1
Severe COVID-19 and inactivated vaccine in diabetic patients with SARS-CoV-2 infection.严重新型冠状病毒肺炎与严重急性呼吸综合征冠状病毒2感染的糖尿病患者中的灭活疫苗
Chin Med J (Engl). 2025 May 20;138(10):1257-1259. doi: 10.1097/CM9.0000000000003577. Epub 2025 Apr 23.
2
Effectiveness of inactivated and Ad5-nCoV COVID-19 vaccines against SARS-CoV-2 Omicron BA. 2 variant infection, severe illness, and death.新冠病毒奥密克戎 BA.2 变异株感染、重症和死亡的灭活疫苗和 Ad5-nCoV 新冠疫苗有效性。
BMC Med. 2022 Oct 20;20(1):400. doi: 10.1186/s12916-022-02606-8.
3
Neutralizing antibodies and T-cell responses to inactivated SARS-CoV-2 vaccine in COVID-19 convalescents one and a half years after infection.感染新冠病毒一年半后康复者体内针对灭活新冠病毒疫苗的中和抗体及T细胞反应
Virus Res. 2023 Jan 2;323:198977. doi: 10.1016/j.virusres.2022.198977. Epub 2022 Oct 22.
4
Analysis of COVID-19 Incidence and Severity Among Adults Vaccinated With 2-Dose mRNA COVID-19 or Inactivated SARS-CoV-2 Vaccines With and Without Boosters in Singapore.分析新加坡成年人接种 2 剂 mRNA COVID-19 或灭活 SARS-CoV-2 疫苗以及接种加强针后的 COVID-19 发病率和严重程度。
JAMA Netw Open. 2022 Aug 1;5(8):e2228900. doi: 10.1001/jamanetworkopen.2022.28900.
5
Single-cell transcriptomic atlas reveals distinct immunological responses between COVID-19 vaccine and natural SARS-CoV-2 infection.单细胞转录组图谱揭示 COVID-19 疫苗接种和自然 SARS-CoV-2 感染之间的独特免疫反应。
J Med Virol. 2022 Nov;94(11):5304-5324. doi: 10.1002/jmv.28012. Epub 2022 Jul 30.
6
Efficacy and Safety of a Booster Vaccination with Two Inactivated SARS-CoV-2 Vaccines on Symptomatic COVID-19 Infection in Adults: Results of a Double-Blind, Randomized, Placebo-Controlled, Phase 3 Trial in Abu Dhabi.两种灭活严重急性呼吸综合征冠状病毒2疫苗加强接种对成人有症状的冠状病毒病感染的疗效和安全性：在阿布扎比进行的一项双盲、随机、安慰剂对照3期试验的结果
Vaccines (Basel). 2023 Jan 30;11(2):299. doi: 10.3390/vaccines11020299.
7
Reduced antibody response to COVID-19 vaccine composed of inactivated SARS-CoV-2 in diabetic individuals.糖尿病个体对由 SARS-CoV-2 灭活病毒制成的 COVID-19 疫苗的抗体反应降低。
Front Public Health. 2022 Dec 8;10:1025901. doi: 10.3389/fpubh.2022.1025901. eCollection 2022.
8
Inactivated SARS-CoV-2 Vaccine Booster Against Omicron Infection Among Quarantined Close Contacts.接种灭活 SARS-CoV-2 疫苗加强针对奥密克戎感染隔离密切接触者的效果。
JAMA Netw Open. 2023 Oct 2;6(10):e2339507. doi: 10.1001/jamanetworkopen.2023.39507.
9
Effectiveness of Inactivated Coronavirus Disease 2019 Vaccine Against Omicron BA.2.2 Infection in Beijing, China, 2022: A Cohabitation Retrospective Cohort Study.2022年中国北京灭活新型冠状病毒肺炎疫苗对奥密克戎BA.2.2感染的有效性：一项同居回顾性队列研究
Viruses. 2024 Dec 28;17(1):31. doi: 10.3390/v17010031.
10
Pre-existing immunity to SARS-CoV-2 associates with strong T cell responses induced by inactivated COVID-19 vaccines.对严重急性呼吸综合征冠状病毒2（SARS-CoV-2）的既有免疫力与灭活新冠疫苗诱导的强烈T细胞反应相关。
J Med Virol. 2023 Mar;95(3):e28642. doi: 10.1002/jmv.28642.

本文引用的文献

1
Risk phenotypes of diabetes and association with COVID-19 severity and death: an update of a living systematic review and meta-analysis.糖尿病的风险表型与 COVID-19 严重程度和死亡的关系：一项实时系统评价和荟萃分析的更新。
Diabetologia. 2023 Aug;66(8):1395-1412. doi: 10.1007/s00125-023-05928-1. Epub 2023 May 19.
2
Vaccine effectiveness of one, two, and three doses of BNT162b2 and CoronaVac against COVID-19 in Hong Kong: a population-based observational study.BNT162b2 和科兴疫苗一剂、两剂和三剂对香港 COVID-19 的疫苗有效性：基于人群的观察性研究。
Lancet Infect Dis. 2022 Oct;22(10):1435-1443. doi: 10.1016/S1473-3099(22)00345-0. Epub 2022 Jul 15.
3
Effectiveness and safety of SARS-CoV-2 vaccine in real-world studies: a systematic review and meta-analysis.
新型冠状病毒2疫苗在真实世界研究中的有效性和安全性：一项系统评价与荟萃分析
Infect Dis Poverty. 2021 Nov 14;10(1):132. doi: 10.1186/s40249-021-00915-3.
4
Effectiveness of an Inactivated SARS-CoV-2 Vaccine in Chile.智利开展的灭活 SARS-CoV-2 疫苗有效性研究
N Engl J Med. 2021 Sep 2;385(10):875-884. doi: 10.1056/NEJMoa2107715. Epub 2021 Jul 7.
5
Diabetes as a risk factor for greater COVID-19 severity and in-hospital death: A meta-analysis of observational studies.糖尿病是 COVID-19 病情加重和住院死亡的危险因素：观察性研究的荟萃分析。
Nutr Metab Cardiovasc Dis. 2020 Jul 24;30(8):1236-1248. doi: 10.1016/j.numecd.2020.05.014. Epub 2020 May 29.